Gastric pentadecapeptide studied for tissue healing, gut protection, and injury recovery.
Derived from human gastric juice, promotes angiogenesis, modulates nitric oxide system, upregulates growth hormone receptors, and accelerates tendon-to-bone healing through multiple pathways.
Extensive animal research showing accelerated healing of tendons, ligaments, muscle, and GI tract. No published human clinical trials to date, though anecdotal reports are widespread.
Common research protocols use 200-500mcg 1-2x daily, either systemically or locally near injury site. No established human dosing.
No documented drug interactions on file.
Not FDA approved. Research chemical status. Recently added to FDA Category 2 list (cannot be compounded).
Not available via 503A/503B compounding pharmacies.
Regulatory data last verified 4/17/2026
Showing 20 of 30 papers. View all on PubMed →